Yichang SanXia Pharmaceutical

Yichang SanXia Pharmaceutical is owned by Humanwell Healthcare.

Humanwell Healthcare is one of the...

• CSI 500.

Humanwell Healthcare is a company listed under the stock ticker 600079 (CN).

Humanwell Healthcare has a direct presence in 2 countries.

Humanwell Healthcare has 3 subsidiaries including Ellen AB, Hubei Gedian Humanwell Pharmaceutical and Yichang SanXia Pharmaceutical.

They are in:

• Pharmaceuticals75%
• Biotechnology25%

View the org chart displaying its 2 main executives

Most searched biographies at Yichang SanXia Pharmaceutical

• Wayne Zheng, Chief Executive Officer
• Linna Zhao, Vice President, Sales

Create your alert
to follow the executive moves at Yichang SanXia Pharmaceutical.

Humanwell Healthcare has 1,973 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Sanofi (France).

Popular M&A news in Pharmaceuticals

• The new name of Cencora is Cencora. (posted on January 24 2023).
• Sun Pharma has announced the acquisition of Concert Pharmaceuticals  (posted on January 24 2023).
• SetPoint Medical has just announced a $80 Million fundraising (posted on January 24 2023).

Popular contacts in Pharmaceuticals

• Theodore Danoff - Chief Medical Officer and Senior Vice President, Clinical Development at Pathalys Pharma
• Danilo Cicmil - Supervisory Board Member at Galenika
• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson

Learn more about the Pharmaceuticals industry >

Press releases by Yichang SanXia Pharmaceutical

Social media about Yichang SanXia Pharmaceutical

• Yichang SanXia Pharmaceutical on Wikipedia, Google News & Yahoo Finance
• Yichang SanXia Pharmaceutical on LinkedIn, Twitter & YouTube

Call Yichang SanXia Pharmaceutical at +86 717...

View the org chart

Register to receive your alert

Report an error